Komori
Broadleaf (3673) · FactMitigated

Decrease in cash and cash equivalents and cash outflows from financing activities

First written in FY2017-Q2. 13 of 36 entries say "Worsened", first in FY2019-Q1. Latest entry: 2026-11-11.

36entries
10years
6from disclosures
Share on X
How it moved
ProgressHeldSoftenedWorseOtherFY2017-Q2 – FY2018MitigatedFY2023-Q3 – FY20242017: 220172018: 420182019: 420192020: 420202021: 320212022: 320222023: 320232024: 320242025: 220252026: 82026
Same theme, other companies

No other company in this theme has enough history to compare yet.

Full recordFilings, disclosures and news, newest first
  1. FY2026-H1MitigatedAnnual report

    「Cash and cash equivalents (hereinafter, “funds”) at the end of the interim consolidated fiscal period decreased by ¥361 million from the end of the previous consolidated fiscal year to ¥3,761 million.」

    Cash and cash equivalents decreased from the end of the previous fiscal year, but the decline narrowed from the ¥684 million decrease in the same period of the previous year. Cash flow from operating activities increased 43.7% year on year.
  2. FY2025WorsenedAnnual report

    「At the end of the consolidated fiscal year, cash and cash equivalents comprised ¥6,897 million provided by operating activities, ¥4,409 million used in investing activities, and ¥2,692 million used in financing activities, resulting in a decrease of ¥185 million from the end of the previous consolidated fiscal year to ¥4,121 million.」

    Cash and cash equivalents decreased by ¥185 million from the end of the previous fiscal year, reversing the increase recorded in the previous fiscal year.
  3. FY2025-H1WorsenedAnnual report

    「Cash and cash equivalents (hereinafter, “funds”) at the end of the interim consolidated fiscal period decreased by ¥684 million from the end of the previous consolidated fiscal year to ¥3,622 million.」

    Cash and cash equivalents decreased by ¥684 million from the end of the previous fiscal year to ¥3,622 million. Cash used in investing activities was ¥2,273 million, and cash used in financing activities was ¥556 million.
  4. FY2024MitigatedAnnual report

    「At the end of the consolidated fiscal year, cash and cash equivalents comprised ¥6,531 million provided by operating activities, ¥4,308 million used in investing activities, and ¥1,835 million used in financing activities, resulting in an increase of ¥386 million from the end of the previous consolidated fiscal year to ¥4,306 million.」

    Cash generated from operating activities increased, and cash and cash equivalents rose by ¥386 million from the end of the previous fiscal year.
  5. FY2024-H1MitigatedAnnual report

    「Cash and cash equivalents (hereinafter, “funds”) at the end of the interim consolidated fiscal period increased by ¥116 million from the end of the previous consolidated fiscal year to ¥4,036 million.」

    Cash and cash equivalents increased by ¥116 million from the end of the previous fiscal year to ¥4,036 million. Cash generated from operating activities also increased 85.5% year on year to ¥2,089 million.
  6. FY2024-Q1MitigatedAnnual report

    「Cash and cash equivalents (hereinafter, “funds”) at the end of the first quarter of the consolidated fiscal period increased by ¥1,310 million from the end of the previous consolidated fiscal year to ¥5,230 million.」

    Cash and cash equivalents increased by ¥1,310 million from the end of the previous consolidated fiscal year, improving from the decrease in the same period of the previous year.
  7. FY2023MitigatedAnnual report

    「At the end of the consolidated fiscal year, cash and cash equivalents (hereinafter, “funds”) comprised ¥3,425 million provided by operating activities, ¥3,669 million used in investing activities, and ¥705 million provided by financing activities, resulting in an increase of ¥463 million from the end of the previous consolidated fiscal year to ¥3,920 million.」

    Cash and cash equivalents turned to an increase from the end of the previous fiscal year, driven by cash generated from operating activities.
  8. FY2023-Q3MitigatedAnnual report

    「Cash and cash equivalents (hereinafter, “funds”) at the end of the third quarter of the consolidated fiscal period increased by ¥164 million from the end of the previous consolidated fiscal year to ¥3,621 million.」

    Cash and cash equivalents turned to an increase from the end of the previous consolidated fiscal year, reaching ¥3,621 million.
  9. FY2023-Q2Slight decrease in cash balance in the second quarterAnnual report

    「Cash and cash equivalents (hereinafter, “funds”) at the end of the second quarter of the consolidated fiscal period decreased by ¥71 million from the end of the previous consolidated fiscal year to ¥3,386 million.」

    Cash and cash equivalents decreased by ¥71 million from the end of the previous consolidated fiscal year to ¥3,386 million. Cash provided by operating activities was ¥1,126 million, cash used in investing activities was ¥1,917 million, and cash provided by financing activities was ¥717 million.
  10. FY2023-Q1Slight decrease in cash balance in the first quarterAnnual report

    「Cash and cash equivalents (hereinafter, “funds”) at the end of the first quarter of the consolidated fiscal period decreased by ¥156 million from the end of the previous consolidated fiscal year to ¥3,301 million.」

    Cash and cash equivalents decreased by ¥156 million from the end of the previous fiscal year. The company spent ¥854 million on the acquisition of intangible assets and recorded a net increase of ¥920 million in short-term borrowings.
  11. FY2022-Q3WorsenedAnnual report

    「Cash and cash equivalents (hereinafter, “funds”) at the end of the third quarter of the consolidated fiscal period decreased by ¥369 million from the end of the previous consolidated fiscal year to ¥3,153 million.」

    Cash and cash equivalents decreased by ¥369 million from the end of the previous fiscal year, compared with a ¥164 million decrease in the previous quarter, representing a larger decline. A net increase of ¥2,198 million in short-term borrowings was also disclosed.
  12. FY2022-Q2WorsenedAnnual report

    「Cash and cash equivalents at the end of the second quarter of the current consolidated fiscal year, hereinafter referred to as “funds,” decreased by ¥311 million from the end of the previous consolidated fiscal year to ¥3,212 million.」

    Cash and cash equivalents decreased by ¥311 million from the end of the previous fiscal year, widening from the ¥164 million decrease from the previous fiscal year-end in the previous quarter.
  13. FY2022-Q1MitigatedAnnual report

    「Cash and cash equivalents at the end of the first quarter of the current consolidated fiscal year, hereinafter referred to as “funds,” decreased by ¥164 million from the end of the previous consolidated fiscal year to ¥3,358 million.」

    Although cash and cash equivalents decreased, the decline narrowed from the ¥382 million decrease from the previous fiscal year-end in the same period of the previous fiscal year, and the period-end balance increased from ¥2,850 million to ¥3,358 million.
  14. FY2021-Q3WorsenedAnnual report

    「Cash and cash equivalents at the end of the third quarter of the current consolidated fiscal year, hereinafter referred to as “funds,” decreased by ¥203 million from the end of the previous consolidated fiscal year to ¥3,029 million.」

    Cash and cash equivalents decreased by ¥203 million from the end of the previous fiscal year, reversing the increase in the previous quarter. Cash inflows from operating activities fell 33.2% year on year, while cash used in investing activities increased 20.1%.
  15. FY2021-Q2MitigatedAnnual report

    「Cash and cash equivalents at the end of the second quarter of the current consolidated fiscal year, hereinafter referred to as “funds,” increased by ¥55 million from the end of the previous consolidated fiscal year to ¥3,287 million.」

    Cash and cash equivalents increased by ¥55 million from the end of the previous fiscal year. Operating cash inflows were secured, while financing activities turned from a ¥23 million outflow to a ¥537 million inflow.
  16. FY2021-Q1WorsenedAnnual report

    「Cash and cash equivalents at the end of the first quarter of the current consolidated fiscal year, hereinafter referred to as “funds,” decreased by ¥382 million from the end of the previous consolidated fiscal year to ¥2,850 million.」

    Cash and cash equivalents decreased by ¥382 million from the end of the previous fiscal year to ¥2,850 million. Investing activities used ¥739 million to acquire intangible assets, while financing activities raised funds through a net increase of ¥1,302 million in short-term borrowings.
  17. FY2020-Q3Decrease in cash balance and narrower cash outflows in the third quarterAnnual report

    「Cash and cash equivalents at the end of the third quarter of the current consolidated fiscal year, hereinafter referred to as “funds,” decreased by ¥265 million from the end of the previous consolidated fiscal year to ¥2,769 million.」

    Cash and cash equivalents decreased by ¥265 million from the end of the previous fiscal year. Operating cash flow was a ¥2,114 million inflow, while investing activities used ¥1,938 million and financing activities used ¥441 million, narrowing the cash outflow from the same period of the previous fiscal year.
  18. FY2020-Q2Slight decrease in cash balance in the second quarterAnnual report

    「Cash and cash equivalents at the end of the second quarter of the current consolidated fiscal year, hereinafter referred to as “funds,” decreased by ¥208 million from the end of the previous consolidated fiscal year to ¥2,826 million.」

    Cash and cash equivalents decreased by ¥208 million from the end of the previous fiscal year. Operating cash flow was a ¥1,100 million inflow, while financing cash flow was a ¥23 million outflow, narrowing the cash outflow from the same period of the previous fiscal year.
  19. FY2020-Q1MitigatedAnnual report

    「Cash and cash equivalents at the end of the first quarter of the current consolidated fiscal year, hereinafter referred to as “funds,” increased by ¥260 million from the end of the previous consolidated fiscal year to ¥3,293 million.」

    The cash balance increased rather than decreased, continuing the trend from the previous fiscal year. Cash used in operating activities also narrowed from ¥538 million in the same period of the previous fiscal year to ¥44 million, while financing activities generated ¥914 million.
  20. FY2019WorsenedAnnual report

    「At the end of the current consolidated fiscal year, funds generated by operating activities were ¥3,762 million, funds used in investing activities were ¥3,990 million and funds used in financing activities were ¥2,366 million. Cash and cash equivalents decreased by ¥2,593 million from the end of the previous consolidated fiscal year to ¥3,034 million.」

    Cash and cash equivalents decreased by ¥2,593 million from the end of the previous fiscal year to ¥3,034 million. Cash used in investing activities increased 59.8% from the previous fiscal year.
  21. FY2019-Q3WorsenedAnnual report

    「Cash and cash equivalents at the end of the third quarter of the current consolidated fiscal year, hereinafter referred to as “funds,” decreased by ¥3,699 million from the end of the previous consolidated fiscal year to ¥1,928 million.」

    Cash and cash equivalents decreased by ¥3,699 million from the end of the previous fiscal year, leaving a balance of ¥1,928 million. Both the size of the decrease and the decline in the balance accelerated from the previous quarter.
  22. FY2019-Q2WorsenedAnnual report

    「Cash and cash equivalents at the end of the second quarter of the current consolidated fiscal year, hereinafter referred to as “funds,” decreased by ¥2,474 million from the end of the previous consolidated fiscal year to ¥3,153 million.」

    Cash and cash equivalents decreased by ¥2,474 million, exceeding the ¥1,080 million decrease in the same period of the previous fiscal year, leaving a balance of ¥3,153 million. Investing activities used ¥1,652 million to acquire intangible assets and ¥1,048 million to acquire investments.
  23. FY2019-Q1WorsenedAnnual report

    「Cash and cash equivalents at the end of the first quarter of the current consolidated fiscal year, hereinafter referred to as “funds,” decreased by ¥3,368 million from the end of the previous consolidated fiscal year to ¥2,258 million.」

    The decrease in cash and cash equivalents widened from ¥1,560 million in the same period of the previous fiscal year to ¥3,368 million, reducing the balance to ¥2,258 million. Operating activities used ¥538 million, while investing activities used ¥1,888 million.
  24. FY2018Narrowing of the full-year decrease in cashAnnual report

    「At the end of the current consolidated fiscal year, funds generated by operating activities were ¥4,566 million, funds used in investing activities were ¥2,496 million and funds used in financing activities were ¥2,409 million. Cash and cash equivalents decreased by ¥344 million from the end of the previous consolidated fiscal year to ¥5,627 million.」

    Cash and cash equivalents decreased by ¥344 million from the end of the previous fiscal year, a narrower decrease than the ¥1,768 million decline in the previous fiscal year.
  25. FY2018-Q3Decrease in cash balance and cash outflows in the third quarterAnnual report

    「Cash and cash equivalents at the end of the third quarter of the current consolidated fiscal year, hereinafter referred to as “funds,” decreased by ¥1,597 million from the end of the previous consolidated fiscal year to ¥4,373 million.」

    Cash and cash equivalents decreased by ¥1,597 million from the end of the previous consolidated fiscal year to ¥4,373 million. Investing activities used ¥1,442 million to acquire intangible assets, while financing activities used ¥967 million for dividend payments, ¥1,006 million for share repurchases and ¥497 million to repay long-term borrowings.
  26. FY2018-Q2Decrease in cash balance and cash outflows in the second quarterAnnual report

    「Cash and cash equivalents at the end of the second quarter of the current consolidated fiscal year, hereinafter referred to as “funds,” decreased by ¥1,080 million from the end of the previous consolidated fiscal year to ¥4,890 million.」

    Cash and cash equivalents decreased by ¥1,080 million from the end of the previous consolidated fiscal year. Investing activities used ¥986 million to acquire intangible assets, while financing activities used ¥1,006 million for share repurchases, ¥487 million for dividends and ¥341 million to repay long-term borrowings.
  27. FY2018-Q1Decrease in cash balance and cash outflows in the first quarterAnnual report

    「Cash and cash equivalents at the end of the first quarter of the current consolidated fiscal year, hereinafter referred to as “funds,” decreased by ¥1,560 million from the end of the previous consolidated fiscal year to ¥4,411 million.」

    Cash and cash equivalents decreased by ¥1,560 million from the end of the previous fiscal year to the end of the first quarter. Disclosed cash outflows from financing activities of ¥487 million for dividend payments and ¥1,006 million for share repurchases, and from investing activities of ¥386 million for the acquisition of intangible assets.
  28. FY2017Disclosed the full-year decrease in funds and investing and financing outlaysAnnual report

    「Cash and cash equivalents decreased by ¥1,768 million from the end of the previous consolidated fiscal year to ¥5,970 million.」

    Cash and cash equivalents decreased by ¥1,768 million for the full year. The acquisition of intangible assets and Tajima shares, dividends, share repurchases and repayment of borrowings were identified as sources of cash outflow.
  29. FY2017-Q3Wider decrease in cash and additional investment outlaysAnnual report

    「Cash and cash equivalents at the end of the third quarter of the current consolidated fiscal year, hereinafter referred to as “funds,” decreased by ¥2,748 million from the end of the previous consolidated fiscal year to ¥4,990 million.」

    The decrease in cash and cash equivalents from the end of the previous fiscal year widened to ¥2,748 million. Investing activities used ¥1,723 million for the acquisition of intangible assets and Tajima shares, while financing activities used ¥2,095 million for dividends, share repurchases and repayment of borrowings.
  30. FY2017-Q2First statedAnnual report

    「Cash and cash equivalents at the end of the second quarter of the current consolidated fiscal year, hereinafter referred to as “funds,” decreased by ¥1,331 million from the end of the previous consolidated fiscal year to ¥6,407 million.」

    Cash and cash equivalents decreased by ¥1,331 million from the end of the previous consolidated fiscal year. Cash used in financing activities was ¥1,424 million, mainly due to dividend payments, share repurchases and repayment of long-term borrowings.
Moved together

"Expansion of the Customer Base and Transformation of the Revenue Structure" moved the same way as this thread, in the same document, in 10 of its 36 moves.

1099776★123456
  1. ★This thread
  2. 1Expansion of the Customer Base and Transformation of the Revenue Structure10×
  3. 2Expansion of Services on the Broadleaf Cloud Platform9×
  4. 3Driving Customer DX and Enhancing the Value of the Service Platform as a Data Exchanger (the Two DX Initiatives)9×
  5. 4Uncertainty over the economic outlook and financial market volatility7×
  6. 5Liquidity risk associated with trade payables, borrowings and other obligations7×
  7. 6Year-on-year declines in net sales, operating income and ordinary income6×

★ is this thread; numbers match the list above. The number on a line is how many documents both moved the same way in; lines between the other threads count the documents they moved together in too. Threads that move together often sit closer.

When this could move next
No upcoming earnings preview for Broadleaf yet. It last moved in the Earnings presentation of 2026-11-11: "Mitigated".
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.